Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / SHS
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
24,501,946
-
Shares change
-
-1,416,070
-
Total reported value, excl. options
-
$49,722,343
-
Value change
-
-$2,756,929
-
Number of buys
-
18
-
Number of sells
-
-15
-
Price
-
$2.03
Significant Holders of AC Immune SA - SHS (ACIU) as of Q2 2025
46 filings reported holding ACIU - AC Immune SA - SHS as of Q2 2025.
AC Immune SA - SHS (ACIU) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,501,946 shares
.
Largest 10 shareholders include BVF INC/IL (19,822,436 shares), WELLS FARGO & COMPANY/MN (1,024,608 shares), RENAISSANCE TECHNOLOGIES LLC (828,321 shares), ACADIAN ASSET MANAGEMENT LLC (411,696 shares), BlackRock, Inc. (411,307 shares), NORTHERN TRUST CORP (381,354 shares), MILLENNIUM MANAGEMENT LLC (291,532 shares), DEUTSCHE BANK AG\ (253,375 shares), DIMENSIONAL FUND ADVISORS LP (198,686 shares), and CITADEL ADVISORS LLC (145,999 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.